title: Chronic maternal hyperglycemia induced during mid-pregnancy in rats increases RAGE expression, augments hippocampal excitability, and alters behavior of the offspring.
abstract: Maternal diabetes during pregnancy may increase the risk of neurodevelopmental disorders in the offspring by increasing inflammation. A major source of inflammatory signaling observed in diabetes is activation of the receptor for advanced glycation end-products (RAGE), and increased RAGE expression has been reported in psychiatric disorders. Thus, we sought to examine whether maternal diabetes creates a proinflammatory state, triggered largely by RAGE signaling, that alters normal brain development and behavior of the offspring. We tested this hypothesis in rats using the streptozotocin (STZ; 50mg/kg; i.p.) model of diabetes induced during mid-pregnancy. Following STZ treatment, we observed a significant increase in RAGE protein expression in the forebrain of the offspring (postnatal day 1). Data obtained from whole-cell patch clamping of hippocampal neurons in cultures from the offspring of STZ-treated dams revealed a striking increase in excitability. When tested in a battery of behavioral tasks in early adulthood, the offspring of STZ-treated dams had significantly lower prepulse inhibition, reduced anxiety-like behavior, and altered object-place preference when compared to control offspring. In an operant-based strategy set-shifting task, STZ offspring did not differ from controls on an initial visual discrimination or reversal learning but took significantly longer to shift to a new strategy (i.e., set-shift). Insulin replacement with an implantable pellet in the dams reversed the effects of maternal diabetes on RAGE expression, hippocampal excitability, prepulse inhibition and object-place memory, but not anxiety-like behavior or set-shifting. Taken together, these results suggest that chronic maternal hyperglycemia alters normal hippocampal development and behavior of the offspring, effects that may be mediated by increased RAGE signaling in the fetal brain.
authors.affiliation: Dept. of Physiology, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: A R
authors.initials: AR
authors.lastname: Chandna
authors.affiliation: Dept. of Physiology, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Kuhlmann
authors.affiliation: Dept. of Physiology, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: C A
authors.initials: CA
authors.lastname: Bryce
authors.affiliation: Dept. of Physiology, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: Q
authors.initials: Q
authors.lastname: Greba
authors.affiliation: Dept. of Physiology, University of Saskatchewan, Saskatoon, SK, Canada.
authors.forename: V A
authors.initials: VA
authors.lastname: Campanucci
authors.affiliation: Dept. of Physiology, University of Saskatchewan, Saskatoon, SK, Canada. Electronic address: john.howland@usask.ca.
authors.forename: J G
authors.initials: JG
authors.lastname: Howland
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001522:Behavior, Animal / Q000502:physiology*; D004195:Disease Models, Animal; D005260:Female; D005865:Gestational Age; D006624:Hippocampus / Q000166:cytology / Q000378:metabolism*; D006943:Hyperglycemia / Q000139:chemically induced / Q000503:physiopathology*; D018782:Maze Learning / Q000187:drug effects / Q000502:physiology; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology*; D016328:NF-kappa B / Q000378:metabolism; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000503:physiopathology*; D065808:Prepulse Inhibition / Q000187:drug effects; D051381:Rats; D020318:Rats, Long-Evans; D000067759:Receptor for Advanced Glycation End Products / Q000235:genetics / Q000378:metabolism*; D021641:Recognition, Psychology / Q000502:physiology; D013311:Streptozocin / Q000633:toxicity; D013997:Time Factors
chemical_list: D016328:NF-kappa B; D000067759:Receptor for Advanced Glycation End Products; D013311:Streptozocin
keywords: behavioral flexibility; gestational diabetes; hippocampus; neurodevelopmental disorder; recognition memory; sensorimotor gating